Amwell to Participate in Upcoming Investor Conferences
- Amwell's CEO and president, Roy Schoenberg, will lead a virtual discussion on Amwell's Converge Platform on Nov. 8, 2023, hosted by Guggenheim Securities.
- Amwell's CEO and chairman, Ido Schoenberg, and CFO, Robert Shepardson, will participate in the Needham Virtual Healthcare Conference on Nov. 15, 2023.
- Dr. Ido Schoenberg and Mr. Shepardson will participate in one on ones on Nov. 20, 2023, in the BTIG Virtual Health Forum and the Piper Sandler 35th Annual Healthcare Conference on Nov. 29, 2023.
- Dr. Roy Schoenberg will participate in a panel at the Bank of America Virtual Home Care Conference on Dec. 4, 2023.
- None.
- On Nov. 8 2023, Roy Schoenberg, M.D., MPH, Amwell’s CEO and president, will lead a virtual discussion on Amwell’s Converge Platform, at 10 a.m. ET. The event is being hosted by Guggenheim Securities.
- On Nov. 15 2023, Ido Schoenberg, M.D., Amwell’s CEO and chairman, and Robert Shepardson, chief financial officer, Amwell, will participate in the Needham Virtual Healthcare Conference.
- Both Dr. Ido Schoenberg and Mr. Shepardson will participate in one on ones on Nov. 20 2023 in the BTIG Virtual Health Forum as well as the Piper Sandler 35th Annual Healthcare Conference on Nov. 29 2023.
- On Dec. 4 2023, Dr. Roy Schoenberg will participate in a panel at the Bank of America Virtual Home Care Conference.
Audio webcasts will be available following, at https://investors.amwell.com.
About Amwell
Amwell provides a leading hybrid care enablement platform in
©2023 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, ConvergeTM, CarepointTM and the Amwell Logo are registered trademarks or trademarks of American Well Corporation.
Forward-Looking Statements
This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties and are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” or “would,” or the negative of these words or other similar terms or expressions.
Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements represent our beliefs and assumptions only as of the date of this release. These statements, and related risks, uncertainties, factors and assumptions, include, but are not limited to: weak growth and increased volatility in the telehealth market; inability to adapt to rapid technological changes; increased competition from existing and potential new participants in the healthcare industry; changes in healthcare laws, regulations or trends and our ability to operate in the heavily regulated healthcare industry; our ability to comply with federal and state privacy regulations; the significant liability that could result from a cybersecurity breach; and other factors described under ‘Risk Factors’ in our most recent form 10-K filed with the SEC. These risks are not exhaustive. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. Further information on factors that could cause actual results to differ materially from the results anticipated by our forward-looking statements is included in the reports we have filed or will file with the Securities and Exchange Commission. These filings, when available, are available on the investor relations section of our website at investors.amwell.com and on the SEC’s website at www.sec.gov.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231026694906/en/
Investor:
Sue Dooley
sue.dooley@amwell.com
415-602-9167
Media:
Angela Vogen
Press@amwell.com
Source: Amwell
FAQ
When will Roy Schoenberg lead a virtual discussion on Amwell's Converge Platform?
Which conferences will Ido Schoenberg and Robert Shepardson participate in?
Which conferences will Dr. Ido Schoenberg and Mr. Shepardson participate in on Nov. 20 and Nov. 29, 2023?
When will Dr. Roy Schoenberg participate in a panel?
